The Samaritan Alzheimer's Rat Model
- Mimics Human Alzheimer's
- Speeds 'Race for Time' to Find Cure
- Saves Valuable Research Money
LAS VEGAS, Oct. 1 /PRNewswire-FirstCall/ -- Samaritan Pharmaceuticals
(OTC Bulletin Board: SPHC) (http://www.samaritanpharma.com) and Taconic
Farms, Hudson, New York, are pleased to announce they have inked a
worldwide partnering agreement to commercialize "The Samaritan Alzheimer's
Rat Model." The "forgetful" rat model is a research tool used by scientists
to study the effectiveness of their new drugs to treat Alzheimer's disease.
The unique benefits of the rat model lie in its ability,
-- To mimic many features of human Alzheimer's including memory loss,
-- Speed a scientist's "race for time" in finding a cure for the
-- Save scientists valuable research money.
The rat model is now available exclusively through Taconic. Samaritan will receive royalties on net sales. Financial terms were not disclosed.
"Taconic is extremely pleased to offer researchers a new and potentially invaluable weapon in the war on neurodegenerative disease," said Todd Little, President of Taconic. "The rapid time to disease state of the Samaritan Alzheimer's Rat Model will enable investigators to conduct Alzheimer's drug target screening on a much faster timeline than ever before."
The rat model is published in Pharmacology, 2006;76:19-33
"Taconic provides us with an experienced partner to monetize this
unique animal model to 'rat out' Alzheimer's. The rat model is
groundbreaking, in that it offers significant advantages over other options
previously available for the s
|SOURCE Samaritan Pharmaceuticals|
Copyright©2008 PR Newswire.
All rights reserved